Literature DB >> 18202185

Neurodegeneration and neuroinflammation in cdk5/p25-inducible mice: a model for hippocampal sclerosis and neocortical degeneration.

David Muyllaert1, Dick Terwel, Anna Kremer, Kristina Sennvik, Peter Borghgraef, Herman Devijver, Ilse Dewachter, Fred Van Leuven.   

Abstract

The cyclin-dependent kinase cdk5 is atypically active in postmitotic neurons and enigmatic among the kinases proposed as molecular actors in neurodegeneration. We generated transgenic mice to express p25, the N-terminally truncated p35 activator of cdk5, in forebrain under tetracycline control (TET-off). Neuronal expression of p25 (p25(ON)) caused high mortality postnatally and early in life. Mortality was completely prevented by administration of doxycycline in the drinking water of pregnant dams and litters until P42, allowing us to study the action of p25 in adult mouse forebrain. Neuronal p25 triggered neurodegeneration and also microgliosis, rapidly and intensely in hippocampus and cortex. Progressive neurodegeneration was severe with marked neuron loss, causing brain atrophy (40% loss at age 5 months) with nearly complete elimination of the hippocampus. Neurodegeneration did not involve phosphorylation of protein tau or generation of amyloid peptide. Degenerating neurons did not stain for terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling or activated caspase-3 but were marked by FluoroJadeB in early stages. Diseased neurons were always closely associated with activated microglia already very early in the disease process. Primary neurons derived from p25 embryos were more prone to apoptosis than wild-type neurons, and they activated microglial cells in co-culture. The inducible p25 mice present as a model for neurodegeneration in hippocampal sclerosis and neocortical degeneration, with important contributions of activated microglia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18202185      PMCID: PMC2312368          DOI: 10.2353/ajpath.2008.070693

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  57 in total

1.  Controlling genes with tetracyclines.

Authors:  H Bujard
Journal:  J Gene Med       Date:  1999 Sep-Oct       Impact factor: 4.565

2.  Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration.

Authors:  L C Schmued; K J Hopkins
Journal:  Brain Res       Date:  2000-08-25       Impact factor: 3.252

3.  Neurotoxicity induces cleavage of p35 to p25 by calpain.

Authors:  M S Lee; Y T Kwon; M Li; J Peng; R M Friedlander; L H Tsai
Journal:  Nature       Date:  2000-05-18       Impact factor: 49.962

4.  Prominent cerebral amyloid angiopathy in transgenic mice overexpressing the london mutant of human APP in neurons.

Authors:  J Van Dorpe; L Smeijers; I Dewachter; D Nuyens; K Spittaels; C Van Den Haute; M Mercken; D Moechars; I Laenen; C Kuiperi; K Bruynseels; I Tesseur; R Loos; H Vanderstichele; F Checler; R Sciot; F Van Leuven
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

5.  Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein.

Authors:  K Spittaels; C Van den Haute; J Van Dorpe; K Bruynseels; K Vandezande; I Laenen; H Geerts; M Mercken; R Sciot; A Van Lommel; R Loos; F Van Leuven
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

6.  Hyperphosphorylated tau and neurofilament and cytoskeletal disruptions in mice overexpressing human p25, an activator of cdk5.

Authors:  M K Ahlijanian; N X Barrezueta; R D Williams; A Jakowski; K P Kowsz; S McCarthy; T Coskran; A Carlo; P A Seymour; J E Burkhardt; R B Nelson; J D McNeish
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

7.  Coexpression of human cdk5 and its activator p35 with human protein tau in neurons in brain of triple transgenic mice.

Authors:  C Van den Haute; K Spittaels; J Van Dorpe; R Lasrado; K Vandezande; I Laenen; H Geerts; F Van Leuven
Journal:  Neurobiol Dis       Date:  2001-02       Impact factor: 5.996

8.  Transgenic mouse models for Alzheimer's disease: the role of GSK-3B in combined amyloid and tau-pathology.

Authors:  D Muyllaert; D Terwel; P Borghgraef; H Devijver; I Dewachter; F Van Leuven
Journal:  Rev Neurol (Paris)       Date:  2006-10       Impact factor: 2.607

9.  Distribution of chromogranin B-like immunoreactivity in the human hippocampus and its changes in Alzheimer's disease.

Authors:  J Marksteiner; T Lechner; W A Kaufmann; P Gurka; C Humpel; C Nowakowski; H Maier; K A Jellinger
Journal:  Acta Neuropathol       Date:  2000-08       Impact factor: 17.088

10.  Inhibition of neuronal maturation in primary hippocampal neurons from tau deficient mice.

Authors:  H N Dawson; A Ferreira; M V Eyster; N Ghoshal; L I Binder; M P Vitek
Journal:  J Cell Sci       Date:  2001-03       Impact factor: 5.285

View more
  18 in total

1.  Dendritic degeneration, neurovascular defects, and inflammation precede neuronal loss in a mouse model for tau-mediated neurodegeneration.

Authors:  Tomasz Jaworski; Benoit Lechat; David Demedts; Lies Gielis; Herman Devijver; Peter Borghgraef; Hans Duimel; Fons Verheyen; Sebastian Kügler; Fred Van Leuven
Journal:  Am J Pathol       Date:  2011-08-10       Impact factor: 4.307

2.  Mice lacking phosphatase PP2A subunit PR61/B'delta (Ppp2r5d) develop spatially restricted tauopathy by deregulation of CDK5 and GSK3beta.

Authors:  Justin V Louis; Ellen Martens; Peter Borghgraef; Caroline Lambrecht; Ward Sents; Sari Longin; Karen Zwaenepoel; Robert Pijnenborg; Isabelle Landrieu; Guy Lippens; Birgit Ledermann; Jürgen Götz; Fred Van Leuven; Jozef Goris; Veerle Janssens
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-11       Impact factor: 11.205

3.  Curcumin Ameliorates Neuroinflammation, Neurodegeneration, and Memory Deficits in p25 Transgenic Mouse Model that Bears Hallmarks of Alzheimer's Disease.

Authors:  Jeyapriya Raja Sundaram; Charlene Priscilla Poore; Noor Hazim Bin Sulaimee; Tej Pareek; Wei Fun Cheong; Markus R Wenk; Harish C Pant; Sally A Frautschy; Chian-Ming Low; Sashi Kesavapany
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

4.  Differential Neurotoxicity Related to Tetracycline Transactivator and TDP-43 Expression in Conditional TDP-43 Mouse Model of Frontotemporal Lobar Degeneration.

Authors:  L Kukreja; R Shahidehpour; G Kim; J Keegan; K R Sadleir; T Russell; J Csernansky; M Mesulam; R J Vassar; L Wang; H Dong; C Geula
Journal:  J Neurosci       Date:  2018-05-28       Impact factor: 6.167

5.  Fisetin Reduces the Impact of Aging on Behavior and Physiology in the Rapidly Aging SAMP8 Mouse.

Authors:  Antonio Currais; Catherine Farrokhi; Richard Dargusch; Aaron Armando; Oswald Quehenberger; David Schubert; Pamela Maher
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2018-03-02       Impact factor: 6.053

6.  TFP5, a peptide derived from p35, a Cdk5 neuronal activator, rescues cortical neurons from glucose toxicity.

Authors:  B K Binukumar; Ya-Li Zheng; Varsha Shukla; Niranjana D Amin; Philip Grant; Harish C Pant
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

7.  Direct and indirect roles of cyclin-dependent kinase 5 as an upstream regulator in the c-Jun NH2-terminal kinase cascade: relevance to neurotoxic insults in Alzheimer's disease.

Authors:  Kai-Hui Sun; Hyoung-gon Lee; Mark A Smith; Kavita Shah
Journal:  Mol Biol Cell       Date:  2009-09-23       Impact factor: 4.138

8.  Modeling of tau-mediated synaptic and neuronal degeneration in Alzheimer's disease.

Authors:  Tomasz Jaworski; Sebastian Kügler; Fred Van Leuven
Journal:  Int J Alzheimers Dis       Date:  2010-08-24

9.  Activated cyclin-dependent kinase 5 promotes microglial phagocytosis of fibrillar β-amyloid by up-regulating lipoprotein lipase expression.

Authors:  Yuanhui Ma; Jintao Bao; Xuyang Zhao; Hongyan Shen; Junniao Lv; Shuaipeng Ma; Xuefei Zhang; Zeyang Li; Shuxin Wang; Qingsong Wang; Jianguo Ji
Journal:  Mol Cell Proteomics       Date:  2013-07-01       Impact factor: 5.911

10.  AAV-tau mediates pyramidal neurodegeneration by cell-cycle re-entry without neurofibrillary tangle formation in wild-type mice.

Authors:  Tomasz Jaworski; Ilse Dewachter; Benoit Lechat; Sophie Croes; Annelies Termont; David Demedts; Peter Borghgraef; Herman Devijver; Robert K Filipkowski; Leszek Kaczmarek; Sebastian Kügler; Fred Van Leuven
Journal:  PLoS One       Date:  2009-10-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.